Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CDC25A | P30304 | 1/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3049719 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CYP3A4TSHRCDC25ALPAR3 | |
| SCHEMBL274257 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CYP3A4TSHRCDC25ALPAR3 | |
| SCHEMBL3107764 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CYP3A4TSHRCDC25ALPAR3 | |
| SCHEMBL9644644 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CYP3A4TSHRCDC25ALPAR3 | |
| SCHEMBL18699067 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CYP3A4TSHRCDC25ALPAR3 | |
| SCHEMBL1538336 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CYP3A4TSHRCDC25ALPAR3 | |
| SCHEMBL9646107 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CYP3A4TSHRCDC25ALPAR3 | |
| SCHEMBL18675767 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CYP3A4TSHRCDC25ALPAR3 | |
| SCHEMBL22408792 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CYP3A4TSHRCDC25ALPAR3 | |
| SCHEMBL600341 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CYP3A4TSHRCDC25ALPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160222140-A1 | POLYMERIZABLE MIXTURES CONTAINING IONIC GEMINI SURFACTANTS; AND LYOTROPIC LIQUID CRYSTALS, POLYMERS, AND MEMBRANES MADE THEREFROM | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2016-08-04 | — | — | US | claimed |
| US-9394386-B1 | Polymerizable mixtures containing ionic gemini surfactants; and lyotropic liquid crystals, polymers, and membranes made therefrom | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2016-07-19 | — | — | US | claimed |
| US-20160222140-A1 | POLYMERIZABLE MIXTURES CONTAINING IONIC GEMINI SURFACTANTS; AND LYOTROPIC LIQUID CRYSTALS, POLYMERS, AND MEMBRANES MADE THEREFROM | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2016-08-04 | — | — | US | disclosed |
| US-9394386-B1 | Polymerizable mixtures containing ionic gemini surfactants; and lyotropic liquid crystals, polymers, and membranes made therefrom | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2016-07-19 | — | — | US | disclosed |
| US-9348228-B2 | Acid-strippable silicon-containing antireflective coating | GLOBALFOUNDRIES INC. (KY) | 2016-05-24 | — | — | US | disclosed |
| WO-2014107476-A1 | ACID-STRIPPABLE SILICON-CONTAINING ANTIREFLECTIVE COATING | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2014-07-10 | — | — | WO | disclosed |
| US-20140186774-A1 | ACID-STRIPPABLE SILICON-CONTAINING ANTIREFLECTIVE COATING | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2014-07-03 | — | — | US | disclosed |
| US-20100222326-A1 | New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders | UCB PHARMA, S.A. (BE) | 2010-09-02 | — | — | US | disclosed |
| EP-1046078-B1 | LIQUID CRYSTAL DEVICE ALIGNMENT AND METHOD OF MAKING SUCH A DEVICE | HEWLETT PACKARD CO (US) | 2004-05-12 | — | — | EP | disclosed |
| US-6727968-B1 | Liquid crystal device alignment | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2004-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222326-A1 | New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders | CNR2, CNR1, SLC18A2 | ALDH1A1 1186/4885CYP3A4 302/4885TSHR 1696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.